Leftagraph

Every financial statement,
one clean chart.

Search any US-listed company. Data straight from SEC filings.

PROBuild your own list with the screener

UPSTREAM BIO, INC. (UPB) financial statements

Number look wrong? Tell us

Data table
PROBuild your own list with the screener

UPSTREAM BIO, INC. (UPB), most recent 12 months reported: revenue $3.16M, net loss $156.5M, free cash flow -$133.44M. Latest balance sheet on file: liquid cash $261.31M. From SEC filings. Others in Pharmaceutical Preparations: NRX Pharmaceuticals, Inc. · TherapeuticsMD, Inc. · XENETIC BIOSCIENCES, INC. · Polomar Health Services, Inc. · Connect Biopharma Holdings Limited · BIO ESSENCE CORP. · Traws Pharma, Inc. · PMGC HOLDINGS INC.

Stock screener

Watchlist